Author By adminPosted on August 1, 2018April 10, 2024CBP-1008, World’s First Bi-Engaging Ligand-Mediated Drug Conjugate, Approved for Clinical TrialOn August 1, 2018, CBP-1008 for injection, a Class I new drug independently developed by Coherent Biopharma, was approved by SFDA...
